Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1986 1
1987 3
1988 2
1989 1
1990 4
1991 2
1992 2
1993 4
1994 2
1995 2
1996 3
1997 4
1998 4
1999 3
2000 2
2001 3
2002 3
2003 2
2004 5
2005 4
2006 4
2007 3
2008 4
2009 2
2010 3
2012 2
2013 1
2014 1
2015 1
2016 1
2018 2
2019 1
2020 12
2021 12
2022 9
2023 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: shibusawa m. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
Shibusawa M, Kidoguchi K, Tanimoto T. Shibusawa M, et al. In: Gallamini A, Juweid M, editors. Lymphoma [Internet]. Brisbane (AU): Exon Publications; 2021 Dec 28. Chapter 4. In: Gallamini A, Juweid M, editors. Lymphoma [Internet]. Brisbane (AU): Exon Publications; 2021 Dec 28. Chapter 4. PMID: 35226434 Free Books & Documents. Review.
Acute Myeloid Leukemia with Myelodysplasia Related Changes.
Shibusawa M, Tanimoto T. Shibusawa M, et al. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 6. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 6. PMID: 36395311 Free Books & Documents. Review.
Epstein-Barr Virus-Positive Diffuse Large B Cell Lymphoma.
Shibusawa M, Kidoguchi K, Tanimoto T. Shibusawa M, et al. In: Gallamini A, Juweid M, editors. Lymphoma [Internet]. Brisbane (AU): Exon Publications; 2021 Dec 28. Chapter 2. In: Gallamini A, Juweid M, editors. Lymphoma [Internet]. Brisbane (AU): Exon Publications; 2021 Dec 28. Chapter 2. PMID: 35226432 Free Books & Documents. Review.
Ruxolitinib for Acute Graft-versus-Host Disease.
Shibusawa M, Tanimoto T. Shibusawa M, et al. N Engl J Med. 2020 Jul 30;383(5):500-501. doi: 10.1056/NEJMc2020763. N Engl J Med. 2020. PMID: 32726540 No abstract available.
Oral Azacitidine in Patients With Myelodysplastic Syndrome.
Shibusawa M, Kidoguchi K, Tanimoto T. Shibusawa M, et al. J Clin Oncol. 2021 Sep 20;39(27):3091-3092. doi: 10.1200/JCO.21.01126. Epub 2021 Jul 1. J Clin Oncol. 2021. PMID: 34197214 No abstract available.
115 results